The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b

Science Signaling

Volumn 10, Issue 483, 2017, Pages

  Zhou, Wu ^a   Ye, Xiao Lei ^b   Xu, Jun ^a   Cao, Ming Guo ^a   Fang, Zheng Yu ^a   Li, Ling Yun ^c   Guan, Guang Hui ^b   Liu, Qiong ^b   Qian, Yue Hui ^d   Xie, Dong ^e  

^a LISHUI UNIVERSITY   (China)

^b Ningbo College of Health Science   (China)

^c LISHUI PEOPLE S HOSPITAL   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; CYTH3 PROTEIN; GIT2 PROTEIN; IMMUNOGLOBULIN G; LONG UNTRANSLATED RNA; MICRORNA 200B; MICRORNA 200C; MICRORNA LET 7B; NERVE CELL ADHESION MOLECULE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; H19 LONG NON-CODING RNA; MICRORNA; MIRN200 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOLUMINESCENCE; CELL CLONING; CELL ISOLATION; CELL PLASTICITY; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; MESENCHYMAL TO EPITHELIAL TRANSITION; METASTASIS; METASTASIS POTENTIAL; METASTATIC BREAST CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BREAST; BREAST TUMOR; CELL SEPARATION; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PLASTICITY; CELL SEPARATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, LONG NONCODING; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 85020847692     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aak9557     Document Type: Article

References (56)

1. G. P. Gupta, J. Massague, Cancer metastasis: Building a framework. Cell 127, 679-695 (2006).
2. I. J. Fidler, Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 50, 6130-6138 (1990).
3. J. Yang, R. A. Weinberg, Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829 (2008).
4. S. A. Mani, W. Guo, M.-J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang, R. A. Weinberg, The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
5. J. Yang, S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, R. A. Weinberg, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
6. D. Tarin, E. W. Thompson, D. F. Newgreen, The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65, 5996-6000 (2005).
7. J. J. Christiansen, A. K. Rajasekaran, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319-8326 (2006).
8. M. H. Chui, Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step. Int. J. Cancer 132, 1487-1495 (2013).
9. W. Guo, Z. Keckesova, J. L. Donaher, T. Shibue, V. Tischler, F. Reinhardt, S. Itzkovitz, A. Noske, U. Zürrer-Härdi, G. Bell, W. L. Tam, S. A. Mani, A. van Oudenaarden, R. A. Weinberg, Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015-1028 (2012).
10. O. H. Ocaña, R. Córcoles, Á. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, M. A. Nieto, Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724 (2012).
11. J. H. Tsai, J. L. Donaher, D. A. Murphy, S. Chau, J. Yang, Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736 (2012).
12. E. Beerling, D. Seinstra, E. de Wit, L. Kester, D. van der Velden, C. Maynard, R. Schäfer, P. van Diest, E. Voest, A. van Oudenaarden, N. Vrisekoop, J. van Rheenen, Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Rep. 14, 2281-2288 (2016).
13. J. P. Thiery, Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454 (2002).
14. J. Lim, J. P. Thiery, Alternative path to EMT: Regulation of apicobasal polarity in Drosophila. Dev. Cell 21, 983-984 (2011).
15. J. P. Sleeman, J. P. Thiery, SnapShot: The epithelial-mesenchymal transition. Cell 145, 162. e1 (2011).
16. R. Kalluri, R. A. Weinberg, The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
17. J. P. Thiery, H. Acloque, R. Y. J. Huang, M. A. Nieto, Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
18. J. P. Thiery, C. T. Lim, Tumor dissemination: An EMT affair. Cancer Cell 23, 272-273 (2013).
19. R. Soundararajan, A. N. Paranjape, V. Barsan, J. T. Chang, S. A. Mani, A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome. Sci. Rep. 5, 11766 (2015).
20. W. L. Tam, R. A. Weinberg, The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 19, 1438-1449 (2013).
21. P. C. Nowell, The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
22. I. J. Fidler, M. L. Kripke, Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895 (1977).
23. M. J. van de Vijver, Y. D. He, L. J. van't Veer, H. Dai, A. A. M. Hart, D. W. Voskuil, G. J. Schreiber, J. L. Peterse, C. Roberts, M. J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E. T. Rutgers, S. H. Friend, R. Bernards, A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (2002).
24. B. Weigelt, A. M. Glas, L. F. Wessels, A. T. Witteveen, J. L. Peterse, L. J. van't Veer, Gene expression profiles of primary breast tumors maintained in distant metastases. Proc. Natl. Acad. Sci. U.S.A. 100, 15901-15905 (2003).
25. S. Ramaswamy, K. N. Ross, E. S. Lander, T. R. Golub, A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003).
26. L. S. Jacob, S. Vanharanta, A. C. Obenauf, M. Pirun, A. Viale, N. D. Socci, J. Massagué, Metastatic competence can emerge with selection of preexisting oncogenic alleles without a need of new mutations. Cancer Res. 75, 3713-3719 (2015).
27. J. L. van't Veer, H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, S. H. Friend, Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
28. Z. Rong, L. Li, F. Fei, L. Luo, Y. Qu, Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. J. Exp. Clin. Cancer Res. 32, 32 (2013).
29. T. Harada, T. Sakaguchi, K. Inaba, T. Nakamura, K. Kurachi, A. Fukazawa, K. Nakamura, T. Sawayanagi, R. Hara, K. Ida, H. Konno, [Spontaneous regression of hepatocellular carcinomas]. Nihon Shokakibyo Gakkai Zasshi 107, 432-441 (2010).
30. B. Sun, S. Zhang, D. Zhang, Y. Liu, Y. Li, Z. Rong, Y. Zhu, X. Jia, Clusterin is associated with spontaneous breast cancer in TA2 mice. FEBS Lett. 581, 3277-3282 (2007).
31. B. Sun, S. Zhang, D. Zhang, Y. Li, X. Zhao, Y. Luo, Y. Guo, Identification of metastasisrelated proteins and their clinical relevance to triple-negative human breast cancer. Clin. Cancer Res. 14, 7050-7059 (2008).
32. W. Zhou, J. P. Thiery, Loss of Git2 induces epithelial-mesenchymal transition by miR146a- Cnot6L-controlled expression of Zeb1. J. Cell Sci. 126, 2740-2746 (2013).
33. P. A. Gregory, A. G. Bert, E. L. Paterson, S. C. Barry, A. Tsykin, G. Farshid, M. A. Vadas, Y. Khew-Goodall, G. J. Goodall, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
34. S.-M. Park, A. B. Gaur, E. Lengyel, M. E. Peter, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008).
35. E. Raveh, I. J. Matouk, M. Gilon, A. Hochberg, The H19 long non-coding RNA in cancer initiation, progression and metastasis-A proposed unifying theory. Mol. Cancer 14, 184 (2015).
36. I. J. Matouk, D. Halle, E. Raveh, M. Gilon, V. Sorin, A. Hochberg, The role of the oncofetal H19 lncRNA in tumor metastasis: Orchestrating the EMT-MET decision. Oncotarget 7, 3748-3765 (2016).
37. L. Weinmann, J. Höck, T. Ivacevic, T. Ohrt, J. Mütze, P. Schwille, E. Kremmer, V. Benes, H. Urlaub, G. Meister, Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136, 496-507 (2009).
38. M. Rehmsmeier, P. Steffen, M. Hochsmann, R. Giegerich, Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517 (2004).
39. R. T. Premont, A. Claing, N. Vitale, S. J. Perry, R. J. Lefkowitz, The GIT family of ADPribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing. J. Biol. Chem. 275, 22373-22380 (2000).
40. W. Zhou, X. Li, R. T. Premont, Expanding functions of GIT Arf GTPase-activating proteins, PIX Rho guanine nucleotide exchange factors and GIT-PIX complexes. J. Cell Sci. 129, 1963-1974 (2016).
41. P. A. Randazzo, T. Terui, S. Sturch, R. A. Kahn, The amino terminus of ADP-ribosylation factor (ARF) 1 is essential for interaction with Gs and ARF GTPase-activating protein. J. Biol. Chem. 269, 29490-29494 (1994).
42. C. D'Souza-Schorey, P. Chavrier, ARF proteins: Roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7, 347-358 (2006).
43. M. Hafner, A. Schmitz, I. Grüne, S. G. Srivatsan, B. Paul, W. Kolanus, T. Quast, E. Kremmer, I. Bauer, M. Famulok, Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 444, 941-944 (2006).
44. A. N. Kallen, X.-B. Zhou, J. Xu, C. Qiao, J. Ma, L. Yan, L. Lu, C. Liu, J.-S. Yi, H. Zhang, W. Min, A. M. Bennett, R. I. Gregory, Y. Ding, Y. Huang, The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 52, 101-112 (2013).
45. J. E. Talmadge, I. J. Fidler, AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res. 70, 5649-5669 (2010).
46. A. F. Chambers, A. C. Groom, I. C. MacDonald, Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572 (2002).
47. V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, S. Goodison, Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8, 61-74 (2002).
48. J. M. Kozlowski, I. R. Hart, I. J. Fidler, N. Hanna, A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 72, 913-917 (1984).
49. T. Hongu, Y. Yamauchi, Y. Funakoshi, N. Katagiri, N. Ohbayashi, Y. Kanaho, Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis. Small GTPases 7, 47-53 (2016).
50. G. Eades, B. Wolfson, Y. Zhang, Q. Li, Y. Yao, Q. Zhou, lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol. Cancer Res. 13, 330-338 (2015).
51. V. Muralidharan-Chari, H. Hoover, J. Clancy, J. Schweitzer, M. A. Suckow, V. Schroeder, F. J. Castellino, J. S. Schorey, C. D'Souza-Schorey, ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res. 69, 2201-2209 (2009).
52. N. Vitale, W. A. Patton, J. Moss, M. Vaughan, R. J. Lefkowitz, R. T. Premont, GIT proteins, a novel family of phosphatidylinositol 3, 4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6. J. Biol. Chem. 275, 13901-13906 (2000).
53. S. E. Langille, V. Patki, J. K. Klarlund, J. M. Buxton, J. J. Holik, A. Chawla, S. Corvera, M. P. Czech, ADP-ribosylation factor 6 as a target of guanine nucleotide exchange factor GRP1. J. Biol. Chem. 274, 27099-27104 (1999).
54. U. Wellner, J. Schubert, U. C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V. G. Brunton, J. Morton, O. Sansom, J. Schüler, M. P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz, The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11, 1487-1495 (2009).
55. L. Li, J. Tan, Y. Zhang, N. Han, X. Di, T. Xiao, S. Cheng, Y. Gao, Y. Liu, DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling. PLOS ONE 9, e91509 (2014).
56. M. Tu, X. Liu, B. Han, Q. Ge, Z. Li, Z. Lu, J. Wei, G. Song, B. Cai, N. Lv, K. Jiang, S. Wang, Y. Miao, W. Gao, Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression. Mol. Med. Rep. 10, 663-669 (2014).